The Biorevolution Podcast

著者： Louise von Stechow
無料で聴く

  • サマリー

  • The Biorevolution Podcast with Andreas Horchler and Louise von Stechow – father and daughter, journalist and biologist, talking about the technologies of the biorevolution. Can genetic engineering, synthetic biology, and artificial intelligence save humanity from disease, climate change, and overpopulation, or are these technologies the first step towards its downfall? Content and Editing: Louise von Stechow and Andreas Horchler Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics but do not claim to give medical, investment, or life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Image: Kelly Sikkema via Unsplash
    続きを読む 一部表示

あらすじ・解説

The Biorevolution Podcast with Andreas Horchler and Louise von Stechow – father and daughter, journalist and biologist, talking about the technologies of the biorevolution. Can genetic engineering, synthetic biology, and artificial intelligence save humanity from disease, climate change, and overpopulation, or are these technologies the first step towards its downfall? Content and Editing: Louise von Stechow and Andreas Horchler Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics but do not claim to give medical, investment, or life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Image: Kelly Sikkema via Unsplash
博物学 生物科学 科学 自然・生態学
続きを読む 一部表示
エピソード
  • The biorevolution podcast #33

    The biorevolution podcast #33
    2025/04/01
    When the Swiss chemist synthesized and tested the psychedelic compound LSD in the 1930s, he knew he had found a tool to explore the human mind. Indeed, before psychedelics became illegal in the late 1960s, a mountain of evidence had been produced, showing potential benefits of psychedelic-assisted therapy for depression, anxiety, and substance abuse. After a decades-long hiatus, research on psychedelics as a treatment for psychiatric diseases is experiencing a renaissance—and initial results look promising. While the field has seen a setback with the recent request for more data by the FDA for the approval of MDMA for PTSD, research into different psychedelic compounds continues, promising new hopes to battle worldwide mental health crises. In the newest episode of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the history, the promise, and the risks of psychedelics as treatments for psychiatric diseases with neuroscientist, psychedelics expert, and executive coach Galyna Pidpruzhnykova https://www.linkedin.com/in/galynapidpruzhnykova/ https://www.galynapipdpruzhnykova.com/ Galyna also outlines her efforts to develop a psychedelics strategy to battle the mental health crisis in Ukraine, where the Ministry of Health published a draft law for research on psychedelic compounds just a few days after we recorded this podcast. https://www.linkedin.com/feed/update/urn:li:activity:7308180815761330176/ Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
    続きを読む 一部表示
    42 分
  • The biorevolution podcast #32

    The biorevolution podcast #32
    2025/03/03
    This time on the BioRevolution podcast: science itself. While recent surveys show persistently high trust in science worldwide, certain scientific topics have become the subject of intense societal and political debate. This politicization of science puts scientists in a difficult position when they are trying to argue based on facts. The value of facts and evidence-based science seems to be increasingly questioned by those in power and by those in control of assets. If those who make laws and regulate science don’t see evidence and consensus as reliable resources anymore, what will become of progress in biomedicine, which feeds innovation in biotech, pharma, and medicine? Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow Image: via Photoshop AI. Further reading: https://nsf-gov-resources.nsf.gov/2023-04/EndlessFrontier75th_w.pdf https://www.nature.com/articles/s41562-024-02090-5 https://www.nature.com/articles/s41599-024-03909-2 https://www.pewresearch.org/science/2024/11/14/public-trust-in-scientists-and-views-on-their-role-in-policymaking/?utm_source=chatgpt.com https://www.nature.com/articles/d41586-025-00525-1 https://pmc.ncbi.nlm.nih.gov/articles/PMC8793038/ https://www.wissenschaftskommunikation.de/wie-lange-vertraut-man-uns-noch-83325/ https://www.nopatientleftbehind.org/defending-the-foundation-of-american-science https://theweek.com/science/distrust-science-politics-2024-public-trust-vaccines-milk-pandemic https://pmc.ncbi.nlm.nih.gov/articles/PMC11004618/ https://www.nature.com/articles/d41586-024-00238-x https://www.forbes.com/sites/innovationrx/2025/02/19/innovationrx-recursion-launches-fund-for-biotech-startups-hit-by-nih-funding-cuts/
    続きを読む 一部表示
    40 分
  • The biorevolution podcast #31

    The biorevolution podcast #31
    2025/02/03
    In some respects, 2024 has been a record year for AI in biotech, with the $1 billion founding of the antibody-centered biotech company Xaira and the awarding of the Nobel Prize in Chemistry to DeepMind researchers Demis Hassabis, John Jumper, and David Baker. However, despite years of investment and innovation, we still lack an answer to the most pressing question: Will AI revolutionize drug development, or are we in a bubble that is about to burst? In episode 30 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow explore various use cases for AI in biotech—from discovery to clinical development, from chemistry to biology, and from data-centric to algorithm-centric AI strategies—trying to assess where the biggest payoff will be. Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow Image: Lucas Favre, via Unsplash. Further reading: 1. OpenAI has created an AI model for longevity science | MIT Technology Review 2. https://www.techlifesci.com/p/a-google-maps-of-human-cells 3. https://www.cas.org/resources/cas-insights/scientific-breakthroughs-2025-emerging-trends-watch#:~:text=Scientific%20breakthroughs%3A%202025%20emerging%20trends%20to%20watch%201,7%20Quantum%20computing%20getting%20practical%20...%20Weitere%20Elemente 4. Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. | Investor's Business Daily 5. Regeneron CSO George Yancopoulos on AI’s hype and potential 6. Science in 2025: the events to watch for in the coming year 7. Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 - PMC 8. Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs | Reuters 9. Profluent Unveils OpenCRISPR-1, an AI-Designed Gene Editor 10. OpenAI has created an AI model for longevity science | MIT Technology Review 11. Clinical trial trends in 2025: Investments, wearables, and AI 12. What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025? 13. Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics | Deep Genomics 14. U of T researchers develop new approach using quantum computers to accelerate drug discovery | Temerty Faculty of Medicine 15. Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors | Nature Biotechnology 16. What are AI 'world models,' and why do they matter? | TechCrunch 17. Empowering biomedical discovery with AI agents: Cell 18. https://youtu.be/CWEWBgVwFc8?si=dqLn2_qGflGf19xL 19. Virtual lab powered by ‘AI scientists’ super-charges biomedical research 20. A New Kid On the Block: AI World Models In Biotech 21. 2025 AI Trends: Life Sciences Leaders on Data, Digital and AI | ZS 22. Scaling gen AI in the life sciences industry | McKinsey 23. https://www.geeksforgeeks.org/what-is-quantum-ai/ 24. Key takeaways from FDA’s draft guidance on use of AI in drug and biological life cycle | DLA Piper 25. Navigating the EU AI Act: implications for regulated digital medical products | npj Digital Medicine 26. Isomorphic Labs CEO Demis Hassabis bets on biotech’s AI future 27. De novo designed proteins neutralize lethal snake venom toxins | Nature 28. A policy framework for leveraging generative AI to address enduring challenges in clinical trials | npj Digital Medicine 29. TrialGPT: NIH algorithm uses AI to match patients to clinical trials | Association of Health Care Journalists 30. The promise and perils of synthetic data | TechCrunch 31. Profluent | Edit
    続きを読む 一部表示
    40 分

The Biorevolution Podcastに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。